John Warrington

6PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyReaction engineering (excl. nuclear reactions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 16, 2026
BACH2 regulates T cell lineage state to enhance CAR T cell function.

Tien-Ching Chang, Amanda Heard, John Lattin

|Jul 17, 2024
Regulatory Considerations for Genome-Edited T-cell Therapies.

Julie K Jadlowsky, Ju-Fang Chang, David H Spencer

|Jul 09, 2024
Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors.

Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang

|Nov 08, 2023
Targeting of intracellular oncoproteins with peptide-centric CARs.

Mark Yarmarkovich, Quinlen F Marshall, John M Warrington

|May 02, 2023
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction.

Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova

|Jun 11, 2022
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19.

Amanda Heard, Jack H Landmann, Ava R Hansen

Pageof 1